| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 2.86e-08 | 20 | 196 | 6 | GO:0015174 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | SLC38A9 SLC7A11 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC7A3 | 3.10e-08 | 71 | 196 | 9 | GO:0015179 |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 1.05e-07 | 13 | 196 | 5 | GO:0061459 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA1 SLC22A25 SLC38A9 SLC22A23 TCIRG1 SPNS3 HCN2 SLC7A11 KCNK4 SLC2A10 CLCN4 SLC12A9 KCNF1 KCNK15 TMEM38A GPM6A MFSD9 SLC7A7 NIPAL3 SLC7A6 GRM7 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC9A2 SLC7A3 SLC22A1 MFSD5 SLC16A8 | 5.05e-07 | 1180 | 196 | 31 | GO:0022857 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | SLC38A9 SLC7A11 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC7A3 | 9.39e-07 | 105 | 196 | 9 | GO:0015171 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC22A25 SLC38A9 SLC7A11 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC7A3 SLC16A8 | 1.01e-06 | 207 | 196 | 12 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC22A25 SLC38A9 SLC7A11 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC7A3 SLC16A8 | 1.06e-06 | 208 | 196 | 12 | GO:0005342 |
| GeneOntologyMolecularFunction | transporter activity | ABCA1 SLC22A25 SLC38A9 SLC22A23 PEX6 TCIRG1 SPNS3 HCN2 SLC7A11 KCNK4 SLC2A10 CLCN4 SLC12A9 KCNF1 KCNK15 TMEM38A GPM6A MFSD9 SLC7A7 NIPAL3 SLC7A6 GRM7 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC9A2 SLC7A3 SLC22A1 MFSD5 SLC16A8 | 1.11e-06 | 1289 | 196 | 32 | GO:0005215 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC22A25 SLC38A9 SLC7A11 SLC2A10 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC7A3 SLC22A1 SLC16A8 | 1.27e-06 | 293 | 196 | 14 | GO:0008514 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.57e-06 | 83 | 196 | 8 | GO:0015101 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 2.82e-06 | 11 | 196 | 4 | GO:0000099 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC22A25 SLC7A11 SLC2A10 CLCN4 SLC12A9 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC9A2 SLC22A1 SLC16A8 | 7.69e-06 | 296 | 196 | 13 | GO:0015291 |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 7.49e-05 | 9 | 196 | 3 | GO:0015189 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA1 SLC22A25 TCIRG1 SLC7A11 SLC2A10 CLCN4 SLC12A9 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC9A2 SLC22A1 SLC16A8 | 7.77e-05 | 477 | 196 | 15 | GO:0022804 |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 1.92e-04 | 12 | 196 | 3 | GO:0019534 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 2.95e-04 | 33 | 196 | 4 | GO:0072349 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.30e-04 | 61 | 196 | 5 | GO:1901682 | |
| GeneOntologyMolecularFunction | L-cystine transmembrane transporter activity | 5.68e-04 | 4 | 196 | 2 | GO:0015184 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 6.86e-04 | 41 | 196 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | amino acid binding | 7.57e-04 | 73 | 196 | 5 | GO:0016597 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 9.39e-04 | 20 | 196 | 3 | GO:0015172 | |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 9.40e-04 | 5 | 196 | 2 | GO:0000064 | |
| GeneOntologyMolecularFunction | short-chain fatty acid transmembrane transporter activity | 9.40e-04 | 5 | 196 | 2 | GO:0015636 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.33e-03 | 167 | 196 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TCIRG1 HCN2 KCNK4 SLC2A10 CLCN4 SLC12A9 KCNF1 KCNK15 TMEM38A GPM6A NIPAL3 GRM7 SLC1A1 SLC1A4 SLC9A2 SLC22A1 MFSD5 | 1.34e-03 | 758 | 196 | 17 | GO:0015318 |
| GeneOntologyBiologicalProcess | basic amino acid transmembrane transport | 1.48e-08 | 19 | 192 | 6 | GO:1990822 | |
| GeneOntologyBiologicalProcess | basic amino acid transport | 3.97e-08 | 22 | 192 | 6 | GO:0015802 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | SLC38A9 SLC7A11 ACSL6 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC7A3 SLC16A8 | 4.28e-08 | 163 | 192 | 12 | GO:1905039 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | SLC38A9 SLC7A11 ACSL6 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC7A3 SLC16A8 | 5.59e-08 | 167 | 192 | 12 | GO:1903825 |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | SLC38A9 SLC7A11 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC7A3 | 1.19e-07 | 87 | 192 | 9 | GO:1902475 |
| GeneOntologyBiologicalProcess | L-arginine transmembrane transport | 1.85e-07 | 15 | 192 | 5 | GO:1903826 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | SLC38A9 SLC7A11 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC7A3 | 7.70e-07 | 108 | 192 | 9 | GO:0015807 |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.38e-06 | 60 | 192 | 7 | GO:0015804 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC38A9 SLC7A11 PLA2G6 ACSL6 GRM2 SLC7A7 SLC7A6 GRM7 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC7A3 SLC22A1 SLC16A8 | 1.57e-06 | 410 | 192 | 16 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC22A25 SLC38A9 SLC7A11 SLC2A10 PLA2G6 ACSL6 GRM2 SLC7A7 SLC7A6 GRM7 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC7A3 SLC22A1 SLC16A8 | 1.66e-06 | 515 | 192 | 18 | GO:0015711 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC38A9 SLC7A11 PLA2G6 ACSL6 GRM2 SLC7A7 SLC7A6 GRM7 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC7A3 SLC22A1 SLC16A8 | 1.67e-06 | 412 | 192 | 16 | GO:0015849 |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | SLC38A9 SLC7A11 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC7A3 | 1.87e-06 | 120 | 192 | 9 | GO:0003333 |
| GeneOntologyBiologicalProcess | amino acid transport | SLC38A9 SLC7A11 GRM2 SLC7A7 SLC7A6 GRM7 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC7A3 | 2.25e-06 | 195 | 192 | 11 | GO:0006865 |
| GeneOntologyBiologicalProcess | sulfur amino acid transport | 4.87e-06 | 13 | 192 | 4 | GO:0000101 | |
| GeneOntologyBiologicalProcess | intracellular glutamate homeostasis | 1.56e-05 | 6 | 192 | 3 | GO:0090461 | |
| GeneOntologyBiologicalProcess | L-cystine transport | 1.56e-05 | 6 | 192 | 3 | GO:0015811 | |
| GeneOntologyBiologicalProcess | ornithine transport | 2.70e-05 | 7 | 192 | 3 | GO:0015822 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 5.37e-05 | 44 | 192 | 5 | GO:0072337 | |
| GeneOntologyBiologicalProcess | organic cation transport | 6.54e-05 | 145 | 192 | 8 | GO:0015695 | |
| GeneOntologyBiologicalProcess | L-lysine transmembrane transport | 9.08e-05 | 10 | 192 | 3 | GO:1903401 | |
| GeneOntologyBiologicalProcess | intracellular amino acid homeostasis | 9.08e-05 | 10 | 192 | 3 | GO:0080144 | |
| GeneOntologyBiologicalProcess | L-lysine transport | 9.08e-05 | 10 | 192 | 3 | GO:1902022 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.63e-04 | 87 | 192 | 6 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.73e-04 | 88 | 192 | 6 | GO:0010232 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 2.04e-04 | 58 | 192 | 5 | GO:0089718 | |
| GeneOntologyBiologicalProcess | lysine transport | 2.57e-04 | 3 | 192 | 2 | GO:0015819 | |
| GeneOntologyBiologicalProcess | branched-chain amino acid transport | 2.68e-04 | 14 | 192 | 3 | GO:0015803 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | HCN2 SLC7A11 SLC2A10 ACSL6 SLC1A1 SLC1A4 SLC7A1 SLC9A2 SLC7A3 | 3.16e-04 | 230 | 192 | 9 | GO:0098739 |
| GeneOntologyBiologicalProcess | sulfur compound transport | 3.49e-04 | 65 | 192 | 5 | GO:0072348 | |
| Domain | AA-permease/SLC12A_dom | 1.69e-09 | 22 | 193 | 7 | IPR004841 | |
| Domain | AA_permease | 1.69e-09 | 22 | 193 | 7 | PF00324 | |
| Domain | AA_permease_2 | 1.82e-09 | 13 | 193 | 6 | PF13520 | |
| Domain | AA/rel_permease1 | 1.82e-09 | 13 | 193 | 6 | IPR002293 | |
| Domain | MFS | SLC22A25 SLC22A23 SPNS3 SLC2A10 MFSD9 SLC22A9 SLC22A1 MFSD5 SLC16A8 | 1.81e-06 | 108 | 193 | 9 | PS50850 |
| Domain | MFS_dom | SLC22A25 SLC22A23 SPNS3 SLC2A10 MFSD9 SLC22A9 SLC22A1 MFSD5 SLC16A8 | 1.07e-05 | 134 | 193 | 9 | IPR020846 |
| Domain | ConA-like_dom | BTNL8 TRIM34 TRIM22 NRXN3 TRIM46 CNTNAP1 COL18A1 THBS4 CELSR2 ERMAP | 9.66e-05 | 219 | 193 | 10 | IPR013320 |
| Domain | GREB1 | 1.06e-04 | 2 | 193 | 2 | PF15782 | |
| Domain | GREB1 | 1.06e-04 | 2 | 193 | 2 | IPR028422 | |
| Domain | MARVEL | 1.61e-04 | 27 | 193 | 4 | PF01284 | |
| Domain | Marvel | 1.86e-04 | 28 | 193 | 4 | IPR008253 | |
| Domain | MARVEL | 1.86e-04 | 28 | 193 | 4 | PS51225 | |
| Domain | CRAL-bd_toc_tran | 2.23e-04 | 12 | 193 | 3 | IPR001071 | |
| Domain | CRAL_TRIO_N | 2.23e-04 | 12 | 193 | 3 | SM01100 | |
| Domain | Thioredoxin/glutathione_Rdtase | 3.17e-04 | 3 | 193 | 2 | IPR006338 | |
| Domain | Cat_AA_permease | 3.17e-04 | 3 | 193 | 2 | IPR004755 | |
| Domain | Sugar_transporter_CS | 3.17e-04 | 32 | 193 | 4 | IPR005829 | |
| Domain | Laminin_G | 3.29e-04 | 58 | 193 | 5 | IPR001791 | |
| Domain | CRAL/TRIO_N_dom | 4.51e-04 | 15 | 193 | 3 | IPR011074 | |
| Domain | Synaptogyrin | 6.29e-04 | 4 | 193 | 2 | IPR016579 | |
| Domain | GOLD_dom | 9.32e-04 | 19 | 193 | 3 | IPR009038 | |
| Domain | GOLD | 9.32e-04 | 19 | 193 | 3 | PS50866 | |
| Domain | CAT3 | 1.04e-03 | 5 | 193 | 2 | IPR015606 | |
| Domain | AA_permease_C | 1.04e-03 | 5 | 193 | 2 | PF13906 | |
| Domain | Pyr_OxRdtase_I_AS | 1.04e-03 | 5 | 193 | 2 | IPR012999 | |
| Domain | Pyr_redox_dim | 1.04e-03 | 5 | 193 | 2 | PF02852 | |
| Domain | PYRIDINE_REDOX_1 | 1.04e-03 | 5 | 193 | 2 | PS00076 | |
| Domain | CAT_C | 1.04e-03 | 5 | 193 | 2 | IPR029485 | |
| Domain | LamG | 1.09e-03 | 44 | 193 | 4 | SM00282 | |
| Domain | FRI | 1.09e-03 | 20 | 193 | 3 | SM00063 | |
| Domain | MFS_1 | 1.21e-03 | 77 | 193 | 5 | PF07690 | |
| Domain | MFS | 1.21e-03 | 77 | 193 | 5 | IPR011701 | |
| Domain | CRAL_TRIO | 1.26e-03 | 21 | 193 | 3 | PF00650 | |
| Domain | - | 1.26e-03 | 21 | 193 | 3 | 1.10.2000.10 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.74e-08 | 32 | 135 | 7 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 2.19e-08 | 33 | 135 | 7 | M188 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC7A11 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC9A2 SLC7A3 | 9.10e-07 | 108 | 135 | 9 | M823 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC7A11 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC9A2 SLC7A3 | 9.84e-07 | 109 | 135 | 9 | MM15074 |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 2.75e-06 | 24 | 135 | 5 | MM17215 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC7A11 SLC2A10 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC9A2 SLC7A3 SLC22A1 SLC16A8 | 3.01e-06 | 238 | 135 | 12 | MM15076 |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 3.41e-06 | 25 | 135 | 5 | M4974 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC7A11 SLC2A10 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC9A2 SLC7A3 SLC22A1 SLC16A8 | 4.79e-06 | 249 | 135 | 12 | M5988 |
| Pathway | WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS | 6.92e-05 | 9 | 135 | 3 | M48047 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA1 TCIRG1 SLC7A11 SLC2A10 CLCN4 SLC7A7 NIPAL3 SLC7A6 SLC1A1 SLC1A4 TFR2 SLC7A9 SLC7A1 SLC9A2 SLC7A3 SLC22A1 PRKAR2B SLC16A8 | 2.28e-04 | 736 | 135 | 18 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA1 TCIRG1 SLC7A11 SLC2A10 CLCN4 SLC7A7 NIPAL3 SLC7A6 SLC1A1 SLC1A4 TFR2 SLC7A9 SLC7A1 SLC9A2 SLC7A3 SLC22A1 SLC16A8 | 2.71e-04 | 681 | 135 | 17 | MM14985 |
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 4.53e-10 | 31 | 201 | 7 | 18195088 | |
| Pubmed | 7.44e-08 | 8 | 201 | 4 | 17714910 | ||
| Pubmed | 1.33e-07 | 9 | 201 | 4 | 15901826 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCNX3 UBE4B OBSCN PEX6 TMEM187 PIGG FZD7 PHLDB1 MDN1 PIK3CD ZER1 TLN2 RIPOR1 PLA2G6 PLK3 TXNRD2 ADGRA2 SLC7A1 CELSR2 PRKDC ESPL1 MFSD5 | 5.18e-07 | 1105 | 201 | 22 | 35748872 |
| Pubmed | System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency. | 7.57e-07 | 4 | 201 | 3 | 20463017 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | UBE4B FASTKD5 TRIP12 USP19 SLC12A9 XPO5 ILVBL TMEM201 ADAMTS1 ACAD9 GPS1 SLC7A1 USP5 SEC62 MTR PRKDC OGA ESPL1 CAPN15 | 2.68e-06 | 942 | 201 | 19 | 31073040 |
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | DIS3L PTK2 USP19 PHLDB1 PYCR2 SEC14L4 TCAF2 DPYSL3 GPS1 NEK7 PLBD2 SEC14L6 ESPL1 | 2.70e-06 | 453 | 201 | 13 | 27113764 |
| Pubmed | 2.74e-06 | 105 | 201 | 7 | 30280653 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | OBSCN NARS1 DGKA ARHGEF17 TRIP12 TMCO4 TMEM260 MDN1 TMEM160 UGT1A9 RNF213 ZBTB26 NIPAL3 MSH6 THBS4 PRKDC | 6.75e-06 | 736 | 201 | 16 | 29676528 |
| Pubmed | 7.12e-06 | 170 | 201 | 8 | 15057823 | ||
| Pubmed | 1.28e-05 | 52 | 201 | 5 | 26590417 | ||
| Pubmed | 3.17e-05 | 209 | 201 | 8 | 26389662 | ||
| Pubmed | Effect of selenium on thioredoxin reductase activity in Txnrd1 or Txnrd2 hemizygous mice. | 3.32e-05 | 2 | 201 | 2 | 17937623 | |
| Pubmed | Focal adhesion kinase is a component of antiviral RIG-I-like receptor signaling. | 3.32e-05 | 2 | 201 | 2 | 22341464 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 15756301 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 12904461 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 29659773 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 17549747 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 11030592 | ||
| Pubmed | Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations. | 3.32e-05 | 2 | 201 | 2 | 29100090 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 20483745 | ||
| Pubmed | Resolution of oxidative stress by thioredoxin reductase: Cysteine versus selenocysteine. | 3.32e-05 | 2 | 201 | 2 | 24624337 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 11584003 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 31705628 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 28739660 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 18350150 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 9614060 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 23732520 | ||
| Pubmed | BRCA1 modulates the autophosphorylation status of DNA-PKcs in S phase of the cell cycle. | 3.32e-05 | 2 | 201 | 2 | 25223785 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 21172426 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 11395000 | ||
| Pubmed | Biosystem Analysis of the Hypoxia Inducible Domain Family Member 2A: Implications in Cancer Biology. | 3.32e-05 | 2 | 201 | 2 | 32085461 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 35008815 | ||
| Pubmed | UNC93B1 is essential for the plasma membrane localization and signaling of Toll-like receptor 5. | 3.32e-05 | 2 | 201 | 2 | 24778236 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 19279247 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 19595745 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 34135509 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 19596993 | ||
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 10721726 | ||
| Pubmed | Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. | 3.32e-05 | 2 | 201 | 2 | 11060283 | |
| Pubmed | 3.32e-05 | 2 | 201 | 2 | 37041638 | ||
| Pubmed | Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues. | 3.32e-05 | 2 | 201 | 2 | 11591158 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 3.39e-05 | 211 | 201 | 8 | 24097068 | |
| Pubmed | 4.93e-05 | 35 | 201 | 4 | 24515614 | ||
| Pubmed | 5.21e-05 | 13 | 201 | 3 | 15369770 | ||
| Pubmed | 5.21e-05 | 13 | 201 | 3 | 16403838 | ||
| Pubmed | Role of chromatin remodeling gene Cecr2 in neurulation and inner ear development. | 5.21e-05 | 13 | 201 | 3 | 21246654 | |
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 17079864 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 12928441 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 26251180 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 20865662 | ||
| Pubmed | Selenium supplementation protects trophoblast cells from oxidative stress. | 9.93e-05 | 3 | 201 | 2 | 23063346 | |
| Pubmed | Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. | 9.93e-05 | 3 | 201 | 2 | 11259642 | |
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 37862170 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 15033454 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 28330900 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 30199535 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 29499643 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 25205036 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 29327078 | ||
| Pubmed | Molecular regulation of antioxidant ability in the hippocampus of EL mice. | 9.93e-05 | 3 | 201 | 2 | 18621028 | |
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 19923370 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 17764108 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 28520920 | ||
| Pubmed | Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter. | 9.93e-05 | 3 | 201 | 2 | 16150593 | |
| Pubmed | Identification of a protein mediating respiratory supercomplex stability. | 9.93e-05 | 3 | 201 | 2 | 22405070 | |
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 30883740 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 19433132 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 22870827 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 20332632 | ||
| Pubmed | Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. | 9.93e-05 | 3 | 201 | 2 | 10455115 | |
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 9334265 | ||
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 28370195 | ||
| Pubmed | THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway. | 9.93e-05 | 3 | 201 | 2 | 32567740 | |
| Pubmed | 9.93e-05 | 3 | 201 | 2 | 30352856 | ||
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 1.01e-04 | 16 | 201 | 3 | 19679677 | |
| Pubmed | UBE4B TRIP12 USP19 BRCA1 TMEM160 TMEM201 GPS1 UBXN6 RNF213 USP5 CAPN15 | 1.23e-04 | 481 | 201 | 11 | 28190767 | |
| Pubmed | 1.72e-04 | 19 | 201 | 3 | 28400473 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 17077281 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 11907091 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 32768484 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 20850175 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 15901730 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 26147384 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 26831100 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 19417012 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 23553196 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 16406804 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 22447976 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 18466105 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 20576130 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 15068970 | ||
| Pubmed | Differential Degradation of TRA2A and PYCR2 Mediated by Ubiquitin E3 Ligase E4B. | 1.98e-04 | 4 | 201 | 2 | 35669517 | |
| Pubmed | Molecular cloning and characterization of cDNA for eukaryotic transcription factor S-II. | 1.98e-04 | 4 | 201 | 2 | 3346229 | |
| Pubmed | Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. | 1.98e-04 | 4 | 201 | 2 | 12757856 | |
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 26546361 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 18627766 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 9878049 | ||
| Pubmed | 1.98e-04 | 4 | 201 | 2 | 17197568 | ||
| Pubmed | Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair. | 1.98e-04 | 4 | 201 | 2 | 20305393 | |
| Interaction | ZNF683 interactions | 1.95e-08 | 10 | 195 | 5 | int:ZNF683 | |
| Interaction | CELF4 interactions | 3.55e-08 | 11 | 195 | 5 | int:CELF4 | |
| Interaction | BEND2 interactions | 6.04e-08 | 12 | 195 | 5 | int:BEND2 | |
| Interaction | C3orf36 interactions | 1.49e-07 | 26 | 195 | 6 | int:C3orf36 | |
| Interaction | PTTG2 interactions | 1.50e-07 | 14 | 195 | 5 | int:PTTG2 | |
| Interaction | MBNL3 interactions | 3.23e-07 | 16 | 195 | 5 | int:MBNL3 | |
| Interaction | PRR34 interactions | 1.45e-06 | 21 | 195 | 5 | int:PRR34 | |
| Interaction | TPRX1 interactions | 1.45e-06 | 21 | 195 | 5 | int:TPRX1 | |
| Interaction | TBX6 interactions | 2.58e-06 | 41 | 195 | 6 | int:TBX6 | |
| Interaction | TSPAN15 interactions | PCNX3 PIGG XPO5 UNC93B1 TMEM201 ACAD9 MFSD9 SLC7A6 SLC22A9 SLC7A1 CELSR2 SYNGR2 FZD10 | 3.08e-06 | 276 | 195 | 13 | int:TSPAN15 |
| Interaction | SYNGR1 interactions | 1.10e-05 | 109 | 195 | 8 | int:SYNGR1 | |
| Interaction | ZNF385C interactions | 1.53e-05 | 33 | 195 | 5 | int:ZNF385C | |
| Interaction | HLX interactions | 2.73e-05 | 37 | 195 | 5 | int:HLX | |
| Interaction | ZCCHC14 interactions | 2.73e-05 | 37 | 195 | 5 | int:ZCCHC14 | |
| Interaction | C10orf55 interactions | 3.91e-05 | 65 | 195 | 6 | int:C10orf55 | |
| Interaction | FAM222B interactions | 5.12e-05 | 42 | 195 | 5 | int:FAM222B | |
| Interaction | FATE1 interactions | 5.34e-05 | 100 | 195 | 7 | int:FATE1 | |
| Interaction | POU2F1 interactions | 5.35e-05 | 175 | 195 | 9 | int:POU2F1 | |
| Interaction | SAMD11 interactions | 5.75e-05 | 43 | 195 | 5 | int:SAMD11 | |
| Interaction | BICRAL interactions | 5.75e-05 | 43 | 195 | 5 | int:BICRAL | |
| Interaction | RHOXF2 interactions | 6.86e-05 | 104 | 195 | 7 | int:RHOXF2 | |
| Interaction | SP4 interactions | 8.00e-05 | 46 | 195 | 5 | int:SP4 | |
| Interaction | YIPF3 interactions | PCNX3 FASTKD5 UNC93B1 GPM6A SLC1A1 SYNGR2 SYNGR1 FZD10 MFSD5 | 8.56e-05 | 186 | 195 | 9 | int:YIPF3 |
| Interaction | DAZAP2 interactions | 8.56e-05 | 186 | 195 | 9 | int:DAZAP2 | |
| Interaction | KRTAP19-1 interactions | 8.89e-05 | 47 | 195 | 5 | int:KRTAP19-1 | |
| Interaction | OXER1 interactions | 1.20e-04 | 50 | 195 | 5 | int:OXER1 | |
| Interaction | RBPMS2 interactions | 1.55e-04 | 83 | 195 | 6 | int:RBPMS2 | |
| Interaction | GPR45 interactions | PEX6 FASTKD5 PIGG TUBGCP4 MDN1 XPO5 RNF213 SLC7A6 MSH6 SLC7A1 SYNGR2 | 1.71e-04 | 300 | 195 | 11 | int:GPR45 |
| Interaction | RIPPLY1 interactions | 1.89e-04 | 55 | 195 | 5 | int:RIPPLY1 | |
| Interaction | ADGRE5 interactions | 1.92e-04 | 163 | 195 | 8 | int:ADGRE5 | |
| Interaction | OPALIN interactions | 2.07e-04 | 209 | 195 | 9 | int:OPALIN | |
| Interaction | UNC93B1 interactions | FASTKD5 PIGG MDN1 XPO5 UNC93B1 TM4SF18 ILVBL ACAD9 RNF213 MSH6 SEC62 SYNGR1 PRKDC | 2.22e-04 | 417 | 195 | 13 | int:UNC93B1 |
| Cytoband | 13q21.1 | 1.91e-09 | 13 | 201 | 5 | 13q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q21 | 1.37e-05 | 117 | 201 | 6 | chr13q21 | |
| Cytoband | 12p12.1-p11.2 | 1.91e-05 | 2 | 201 | 2 | 12p12.1-p11.2 | |
| Cytoband | 15q15.3 | 1.77e-04 | 25 | 201 | 3 | 15q15.3 | |
| Cytoband | 7q22 | 6.23e-04 | 38 | 201 | 3 | 7q22 | |
| Cytoband | 17q25.3 | 1.05e-03 | 101 | 201 | 4 | 17q25.3 | |
| GeneFamily | Solute carriers | SLC22A25 SLC38A9 SLC22A23 SLC7A11 SLC2A10 SLC12A9 SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC22A9 SLC7A1 SLC9A2 SLC7A3 SLC22A1 SLC16A8 | 2.81e-09 | 395 | 128 | 17 | 752 |
| GeneFamily | SEC14 family|PRELI domain containing | 6.83e-06 | 6 | 128 | 3 | 1063 | |
| Coexpression | GSE27786_NKCELL_VS_ERYTHROBLAST_DN | KCNK4 MAVS STRC GRM2 SLC1A4 SNED1 ZSCAN20 GPR150 FZD10 CLDN5 | 2.99e-06 | 200 | 197 | 10 | M4854 |
| Coexpression | GSE27786_NKTCELL_VS_ERYTHROBLAST_DN | SPNS3 WDR76 KCNK4 DUOX1 MAVS TRIM46 SEMA4G BBS10 SLC7A9 THBS4 | 2.99e-06 | 200 | 197 | 10 | M4867 |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | SLC22A23 FAM110D NARS1 PTK2 TXNRD1 CD82 MDN1 CLCN4 BRCA1 TLN2 RIPOR1 SEC14L4 ACAD9 TXNRD2 APOBEC3B TFR2 SEC14L3 COL18A1 MSH6 SLC7A1 UTP18 SYNGR1 ERMAP PRKAR2B PRKDC MARVELD2 | 3.59e-06 | 1271 | 197 | 26 | M39197 |
| Coexpression | CHYLA_CBFA2T3_TARGETS_DN | SLC38A9 SLC22A23 PTK2 FZD7 CD82 MFSD9 ACOT6 SLC7A7 TFR2 MARVELD2 | 1.83e-05 | 246 | 197 | 10 | M2206 |
| Coexpression | CHYLA_CBFA2T3_TARGETS_DN | SLC38A9 SLC22A23 PTK2 FZD7 CD82 MFSD9 ACOT6 SLC7A7 TFR2 MARVELD2 | 3.25e-05 | 263 | 197 | 10 | MM1295 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | BTNL8 FAM110D PCDH12 TM4SF18 ITGA10 ADGRA2 SNED1 SLC7A1 CLDN5 MARVELD2 | 1.95e-08 | 197 | 197 | 10 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | BTNL8 FAM110D PCDH12 TM4SF18 ITGA10 ADGRA2 SNED1 SLC7A1 CLDN5 MARVELD2 | 1.95e-08 | 197 | 197 | 10 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | FAM110D PCDH12 TM4SF18 ITGA10 ADGRA2 SLC1A1 COL18A1 SLC7A1 TMEM45B CLDN5 | 2.15e-08 | 199 | 197 | 10 | 1295f34a350bf48987e2fad411aaac3630efd3f1 |
| ToppCell | (03)_Secretory-(0)_uninjured|(03)_Secretory / shred by cell type and Timepoint | SLC22A23 CD82 FCGBP UNC93B1 SEC14L4 SLC1A1 TENT5B SEC14L3 SYNGR1 | 8.63e-08 | 174 | 197 | 9 | ebdddb5091afcc49ab533c890f260f709880c5f9 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | BTNL8 FAM110D PCDH12 TM4SF18 ADGRA2 SNED1 SLC7A1 CLDN5 MARVELD2 | 2.48e-07 | 197 | 197 | 9 | 9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FAM110D PCDH12 WDR76 TMEM38A TM4SF18 GPM6A ACSL6 ZBTB26 CLDN5 | 2.59e-07 | 198 | 197 | 9 | c77421898cc84ae2e8cc335087198dd05f13bfa5 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PCDH12 SLC7A11 TM4SF18 ADGRA2 SLC1A4 COL18A1 SLC7A1 TMEM45B CLDN5 | 2.59e-07 | 198 | 197 | 9 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PCDH12 SLC7A11 TM4SF18 ADGRA2 SLC1A4 COL18A1 SLC7A1 TMEM45B CLDN5 | 2.59e-07 | 198 | 197 | 9 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PCDH12 SLC7A11 TM4SF18 ADGRA2 SLC1A4 COL18A1 SLC7A1 TMEM45B CLDN5 | 2.70e-07 | 199 | 197 | 9 | 9c40b3ee39860e9d8edafd007daec11abdd95435 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PCDH12 SLC7A11 TM4SF18 ADGRA2 SLC1A4 COL18A1 SLC7A1 TMEM45B CLDN5 | 2.70e-07 | 199 | 197 | 9 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.95e-07 | 169 | 197 | 8 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-06 | 179 | 197 | 8 | dc6cd46fa652b296ddbc41855f6377946d0a4cdc | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|normal_Lung / Location, Cell class and cell subclass | 1.70e-06 | 184 | 197 | 8 | 7ee98acda030366ac6cf3890a6d93fd0426712ed | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 2.07e-06 | 189 | 197 | 8 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.04e-06 | 199 | 197 | 8 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 199 | 197 | 8 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.04e-06 | 199 | 197 | 8 | cefc3b50f65e95da850e4720c7b44bf584073491 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 199 | 197 | 8 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.04e-06 | 199 | 197 | 8 | aaa460c389cd6d38a13ba1a446f91a94f9573ad8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 199 | 197 | 8 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 199 | 197 | 8 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 199 | 197 | 8 | c5c12c8288fe868322bae9d691b91fee953ceb3e | |
| ToppCell | Influenza-Influenza_Severe-Others-RBC|Influenza_Severe / Disease, condition lineage and cell class | 3.04e-06 | 199 | 197 | 8 | da0fec0a492bc3827d9066d2590bcd466cd45564 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 200 | 197 | 8 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-06 | 200 | 197 | 8 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.05e-06 | 159 | 197 | 7 | a8fa49dc2e6ad726d1f4f2b30693fecd1151a485 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.63e-06 | 164 | 197 | 7 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.63e-06 | 164 | 197 | 7 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.63e-06 | 164 | 197 | 7 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.63e-06 | 164 | 197 | 7 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-06 | 165 | 197 | 7 | 680bdd150bc0a4e50244e57b1226a9b06a6bdbc9 | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-06 | 165 | 197 | 7 | af423307af484661284793a08091777d998e6fba | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-06 | 165 | 197 | 7 | a761e0a36d5da8fec916d684f81e60f5590fd9ee | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.72e-06 | 167 | 197 | 7 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.72e-06 | 167 | 197 | 7 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-05 | 168 | 197 | 7 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.18e-05 | 172 | 197 | 7 | c3a99828838af3b85c8c885d69cc8018f55ced50 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 174 | 197 | 7 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 177 | 197 | 7 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 177 | 197 | 7 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-05 | 180 | 197 | 7 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.70e-05 | 182 | 197 | 7 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-05 | 183 | 197 | 7 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 184 | 197 | 7 | 72b42dfca7e9c0257f11d8242531e843271871a7 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 184 | 197 | 7 | c6f4537ae8b6e8fde1be17df14629b7b49b4997c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 184 | 197 | 7 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 1.90e-05 | 124 | 197 | 6 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 197 | 7 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 197 | 7 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 197 | 7 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.09e-05 | 188 | 197 | 7 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.24e-05 | 190 | 197 | 7 | 8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 192 | 197 | 7 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-05 | 192 | 197 | 7 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.39e-05 | 192 | 197 | 7 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-05 | 193 | 197 | 7 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 2.47e-05 | 193 | 197 | 7 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 194 | 197 | 7 | 550e61a40be2baa59520aaf5912bb99ad094ba15 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-05 | 194 | 197 | 7 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-05 | 194 | 197 | 7 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-05 | 194 | 197 | 7 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.59e-05 | 131 | 197 | 6 | d5bc40cd585582856881081b7130dec3515b4ae0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 195 | 197 | 7 | 25703e3c2e0512ef12e7aa389fad3968c3f13905 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 196 | 197 | 7 | 9554ac6eb5f381bcde3ba40c32aa3fc340974540 | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.73e-05 | 196 | 197 | 7 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.73e-05 | 196 | 197 | 7 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 197 | 197 | 7 | 15d1e0dffee8f5ba8cee37adfbfa0551a0cd5e15 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.91e-05 | 198 | 197 | 7 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-05 | 198 | 197 | 7 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Endothelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.91e-05 | 198 | 197 | 7 | d4a4e5c358d26d09ff27541ce49d0db75c1cd08e | |
| ToppCell | Endothelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.91e-05 | 198 | 197 | 7 | b93effa428ec036542fa21647dfef9589c64640f | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 2.91e-05 | 198 | 197 | 7 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.91e-05 | 198 | 197 | 7 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | Bronchial_Biopsy-Endothelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.91e-05 | 198 | 197 | 7 | ec80b05b8a1800c341b5741bf3e57213308398a7 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 199 | 197 | 7 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 199 | 197 | 7 | 892ca0dc9928d3985bf99de8afc68c06d22e6e2e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.01e-05 | 199 | 197 | 7 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 200 | 197 | 7 | 3653002c805c314043e2a7b0c9980dfe952dc53e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.11e-05 | 200 | 197 | 7 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.11e-05 | 200 | 197 | 7 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.11e-05 | 200 | 197 | 7 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.33e-05 | 137 | 197 | 6 | ed81624b9167255ce88dcf6ad7f1636376ea0525 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.33e-05 | 137 | 197 | 6 | 47859aa25f32367461c1ec75ed9060bee430c6b7 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 144 | 197 | 6 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.14e-05 | 148 | 197 | 6 | fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.13e-05 | 157 | 197 | 6 | c488ab1d6c6c7e5c2f4426805d1366b44711a031 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.13e-05 | 157 | 197 | 6 | ffb8dd381e6b9adc5283fb49586e8bd63773c8d6 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.64e-05 | 159 | 197 | 6 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.91e-05 | 160 | 197 | 6 | 04714d0b9bad4c11fa193ed168e2d84a4df39e2e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 8.76e-05 | 163 | 197 | 6 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | BAL-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 8.76e-05 | 163 | 197 | 6 | 7047d3ba847930f42a6d5f71e18d49f3071c6409 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.37e-05 | 165 | 197 | 6 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.37e-05 | 165 | 197 | 6 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.37e-05 | 165 | 197 | 6 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.37e-05 | 165 | 197 | 6 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 167 | 197 | 6 | 7ec032a98a13504d15c7e3a4e259278d07f40180 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 167 | 197 | 6 | 49d9220f22d10ff06c0512c9c40c26ad51728e4f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 167 | 197 | 6 | 5e3588eee73693a996bb4846427cf0038ceafbca | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.00e-04 | 167 | 197 | 6 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 168 | 197 | 6 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| Drug | sarcolysin | SLC7A11 LILRA6 SLC7A7 SLC7A6 CR2 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC7A3 | 2.32e-06 | 172 | 194 | 10 | CID000004053 |
| Drug | prazosin hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | KLHL24 TCIRG1 ARHGEF17 GREB1L PHLDB1 PIK3CD ITGA10 SYNGR1 GREB1 OGA | 6.78e-06 | 194 | 194 | 10 | 942_UP |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | IFT140 KLHL24 WDR76 USP19 ZER1 UBXN6 SEMA4G SLC7A1 USP5 ERMAP | 7.76e-06 | 197 | 194 | 10 | 3174_DN |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; MCF7; HT_HG-U133A | ARHGEF17 SLC7A11 GASK1B CD82 ZER1 RIPOR1 PLK3 SLC1A4 SLC7A1 ERMAP | 8.11e-06 | 198 | 194 | 10 | 3569_DN |
| Drug | AC1L1BXF | 8.24e-06 | 85 | 194 | 7 | CID000001650 | |
| Drug | potassium | UBE4B HDAC8 TCIRG1 HCN2 SLC7A11 KCNK4 CLCN4 SLC12A9 KCNF1 PIK3CD KCNK15 GRM2 SLC7A7 GRM7 SLC1A1 SLC1A4 SLC7A1 SLC9A2 SLC7A3 RNPEP MTR PRKAR2B CLDN5 | 1.74e-05 | 1008 | 194 | 23 | CID000000813 |
| Drug | SB-C | 2.72e-05 | 69 | 194 | 6 | CID005331010 | |
| Drug | Mifepristone [84371-65-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.38e-05 | 187 | 194 | 9 | 7183_UP | |
| Drug | dl-Lysine | SLC7A11 PTK2 ILVBL SLC7A7 SLC7A6 SLC1A1 SLC1A4 SLC7A9 SLC7A1 SLC7A3 RNPEP | 4.15e-05 | 290 | 194 | 11 | CID000000866 |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HT_HG-U133A | IFT140 PCDH12 GREB1L PHLDB1 NRXN3 ZER1 COL7A1 CELSR2 SLC22A1 | 4.33e-05 | 193 | 194 | 9 | 6734_DN |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | KLHL24 PCDH12 ARHGEF17 SLC7A11 CD82 PLA2G6 CNTNAP1 ADGRA2 SLC7A1 | 4.69e-05 | 195 | 194 | 9 | 4960_UP |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; PC3; HT_HG-U133A | 4.88e-05 | 196 | 194 | 9 | 6760_DN | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.88e-05 | 196 | 194 | 9 | 6596_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.88e-05 | 196 | 194 | 9 | 4965_DN | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 4.88e-05 | 196 | 194 | 9 | 3881_DN | |
| Drug | Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A | 4.88e-05 | 196 | 194 | 9 | 3878_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 5.08e-05 | 197 | 194 | 9 | 3885_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 5.08e-05 | 197 | 194 | 9 | 3940_DN | |
| Drug | Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; PC3; HT_HG-U133A | 5.28e-05 | 198 | 194 | 9 | 7302_UP | |
| Drug | 0198306-0000 [212631-61-3]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.28e-05 | 198 | 194 | 9 | 7064_UP | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 5.28e-05 | 198 | 194 | 9 | 3581_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.28e-05 | 198 | 194 | 9 | 3905_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 5.28e-05 | 198 | 194 | 9 | 1507_UP | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A | 5.49e-05 | 199 | 194 | 9 | 2625_UP | |
| Drug | sodium | TCIRG1 HCN2 SLC7A11 SLC2A10 SLC12A9 ERP29 ADAMTS1 SLC7A7 SLC7A6 SLC1A1 LDHC PLBD2 SLC1A4 SLC7A9 SLC7A1 SLC9A2 SLC7A3 RNPEP MTR PRKAR2B CLDN5 | 5.93e-05 | 944 | 194 | 21 | CID000000923 |
| Drug | Vitamin E | 6.99e-05 | 10 | 194 | 3 | DB00163 | |
| Drug | potassium tellurate(IV) | 7.22e-05 | 2 | 194 | 2 | ctd:C026899 | |
| Disease | obsolete aging, cognition | 3.59e-08 | 15 | 197 | 5 | EFO_0003925, GO_0007568 | |
| Disease | Tinnitus, wellbeing measurement | 3.83e-06 | 96 | 197 | 7 | EFO_0007869, HP_0000360 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 5.34e-06 | 66 | 197 | 6 | EFO_0007708 | |
| Disease | mosaic loss of chromosome Y measurement | 2.02e-04 | 80 | 197 | 5 | EFO_0007783 | |
| Disease | response to cyclophosphamide, response to antineoplastic agent | 2.64e-04 | 4 | 197 | 2 | GO_0097327, GO_1902518 | |
| Disease | Schizophrenia | ABCA1 FASTKD5 NRXN3 BRCA1 PLA2G6 GPM6A ACSL6 GPS1 ACOT6 GRM2 GRM7 SLC1A1 GPR153 SYNGR1 MTR CLDN5 | 3.09e-04 | 883 | 197 | 16 | C0036341 |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 5.43e-04 | 99 | 197 | 5 | EFO_0004574, EFO_0008595 | |
| Disease | triacylglycerol 52:6 measurement | 6.05e-04 | 25 | 197 | 3 | EFO_0010418 | |
| Disease | Libman-Sacks Disease | 6.17e-04 | 58 | 197 | 4 | C0242380 | |
| Disease | gamma-enolase measurement | 6.54e-04 | 6 | 197 | 2 | EFO_0021845 | |
| Disease | Adult only | 6.54e-04 | 6 | 197 | 2 | C3842001 | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 6.54e-04 | 6 | 197 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 6.79e-04 | 104 | 197 | 5 | EFO_0008591, EFO_0008595 | |
| Disease | pseudotumor cerebri | 6.80e-04 | 26 | 197 | 3 | EFO_1001132 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 8.49e-04 | 28 | 197 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | alcohol dependence measurement, electroencephalogram measurement | 9.11e-04 | 7 | 197 | 2 | EFO_0004357, EFO_0007835 | |
| Disease | breast carcinoma (is_marker_for) | 1.01e-03 | 66 | 197 | 4 | DOID:3459 (is_marker_for) | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.15e-03 | 31 | 197 | 3 | EFO_0022249 | |
| Disease | Lupus Erythematosus, Systemic | 1.32e-03 | 71 | 197 | 4 | C0024141 | |
| Disease | X-12844 measurement | 1.55e-03 | 9 | 197 | 2 | EFO_0021339 | |
| Disease | estrogen measurement | 1.93e-03 | 10 | 197 | 2 | EFO_0011007 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 2.31e-03 | 137 | 197 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | Systemic lupus erythematosus | 2.34e-03 | 11 | 197 | 2 | cv:C0024141 | |
| Disease | Malignant neoplasm of breast | OBSCN PTHLH SLC2A10 BRCA1 OTOF NLRP8 COL7A1 ADAMTS1 MFSD9 UGT1A9 SLC7A7 APOBEC3B SLC22A9 MSH6 SLC9A2 MTR | 2.40e-03 | 1074 | 197 | 16 | C0006142 |
| Disease | Combined immunodeficiency | 2.59e-03 | 41 | 197 | 3 | C0494261 | |
| Disease | methionine sulfone measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0800072 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 2.80e-03 | 12 | 197 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | triacylglycerol 58:12 measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0010439 | |
| Disease | ornithine measurement | 3.17e-03 | 44 | 197 | 3 | EFO_0009776 | |
| Disease | Intellectual Disability | 3.26e-03 | 447 | 197 | 9 | C3714756 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 3.38e-03 | 45 | 197 | 3 | EFO_0022236 | |
| Disease | serum gamma-glutamyl transferase measurement | PCNX3 NARS1 TMEM187 ITK ZER1 TRIM46 SGIP1 UGT1A9 JMJD1C SEMA4G SLC9A2 CELSR2 PTCD1 SLC22A1 | 3.47e-03 | 914 | 197 | 14 | EFO_0004532 |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 3.97e-03 | 96 | 197 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | age at menopause | 4.32e-03 | 302 | 197 | 7 | EFO_0004704 | |
| Disease | Replication Error Phenotype | 4.40e-03 | 15 | 197 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 4.40e-03 | 15 | 197 | 2 | C0920269 | |
| Disease | liver volume | 4.40e-03 | 15 | 197 | 2 | EFO_0600048 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 4.40e-03 | 15 | 197 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 4.43e-03 | 99 | 197 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | Adenoid Cystic Carcinoma | 4.59e-03 | 100 | 197 | 4 | C0010606 | |
| Disease | free cholesterol in large LDL measurement | 4.82e-03 | 51 | 197 | 3 | EFO_0022176 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 4.82e-03 | 51 | 197 | 3 | cv:CN043650 | |
| Disease | maximal oxygen uptake measurement, response to exercise | 5.00e-03 | 16 | 197 | 2 | EFO_0004887, EFO_0007768 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 5.37e-03 | 53 | 197 | 3 | EFO_0022258 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 5.65e-03 | 17 | 197 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Moyamoya Disease | 5.65e-03 | 17 | 197 | 2 | C0026654 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 5.65e-03 | 17 | 197 | 2 | EFO_0022232 | |
| Disease | Metastatic melanoma | 5.66e-03 | 54 | 197 | 3 | C0278883 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 6.27e-03 | 56 | 197 | 3 | EFO_0022250 | |
| Disease | response to clozapine | 6.32e-03 | 18 | 197 | 2 | GO_0097338 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NILSATLYFCIGELG | 126 | P12645 | |
| AGFLFLACISADRYV | 126 | P46092 | |
| RLGFYAEVLFDTCGI | 526 | P78357 | |
| ILFGAAYTCLEAATG | 361 | Q9H4A4 | |
| LCGFYGRHAELRFLD | 246 | Q9UH17 | |
| LENITVLDAGLYGCR | 101 | Q6UX41 | |
| SCLYGVAASALGLFV | 1051 | Q96PE1 | |
| LYEIFTCLGELGAIA | 181 | Q14195 | |
| GCLPVYDALAGEFIR | 156 | P30040 | |
| RLGLGTAFSVCYSAL | 636 | Q14416 | |
| SRANLAAACGGIIYF | 741 | O95477 | |
| YCFGRTVETLLLRFG | 506 | Q9H845 | |
| IDLFGSSRGLCEYRA | 161 | Q3I5F7 | |
| LAVSLVRVFAPYACG | 166 | P51793 | |
| VALRFGSVLGNYSCA | 1491 | Q9HCU4 | |
| AGRVAAGKCFRLYTA | 726 | O60231 | |
| QALLFGGYRDALVCS | 336 | Q8IV53 | |
| ELLLEAYFCGRVGRN | 171 | Q8TAM1 | |
| GAVNEVRCLLGLYFA | 76 | P27701 | |
| RAYSFKVVLLGEGCV | 16 | Q9UL25 | |
| ALLVAVSYCGGFINS | 141 | Q8NH87 | |
| AAALSLCEGVRGAFY | 136 | Q9UHI8 | |
| LCEGVRGAFYLLGEA | 141 | Q9UHI8 | |
| SLCFLGAIAVDRYIS | 131 | Q01726 | |
| GYLFLLGDCQEVTTL | 16 | Q9NPG4 | |
| RSYGALVAFCVAFGL | 341 | O95907 | |
| LDLCILVFRATFGSG | 846 | O75808 | |
| SDGYVGQVCLLSLRA | 1521 | Q96PE2 | |
| GCVAVFYAIAGGLFL | 1046 | Q9NRD9 | |
| LTGYQALRAEGFLCD | 16 | Q8N239 | |
| ASYLQVTEALGLCGR | 106 | Q8N239 | |
| LYEGFCLGFLTQLDR | 986 | Q9NU22 | |
| LRRYVLSFVGCGLAV | 131 | Q6P499 | |
| CIIFGALVHDSRYGR | 176 | A6NDP7 | |
| YFIAALRGCELVDLA | 71 | Q7Z434 | |
| FSGLLLYLCDSFVGA | 1871 | Q4ZG55 | |
| DSGAVGARRFLLCLY | 36 | Q8NBP5 | |
| ISGAAVVCRQLGFAY | 706 | Q96JK4 | |
| NAIGVYGILTLCEAF | 991 | Q86W28 | |
| ASLVGGFLIDCYGRK | 61 | O95528 | |
| YGNVALRTDAGRLFC | 106 | Q9NYG8 | |
| LCYLLVGAAVFDALE | 16 | Q9H427 | |
| LEFLRTCYGGSFLVH | 271 | Q4VC44 | |
| IATILLYAGVALFCG | 31 | P51674 | |
| EEYGVRTCTLIQFLG | 2441 | Q15652 | |
| RSLLAAALLYGFCLG | 956 | Q9H6A9 | |
| EGAAALCGLVYLFAR | 76 | Q16873 | |
| GCVAQLFIYLALGST | 96 | Q8NGV0 | |
| RLAIGSYLCGFLNAS | 141 | Q8NH48 | |
| RCAGFVVGDLYALLT | 626 | Q13608 | |
| GRGQFSEVYRAACLL | 41 | Q8TDX7 | |
| ALSVAGGFVALYVDC | 581 | P39060 | |
| IYGGLCALATFDRQE | 291 | Q13098 | |
| FYTHGCRFIVAEIGL | 156 | Q6NV75 | |
| GYVGCIRDLFIDGRS | 606 | Q9Y4C0 | |
| LNDVSCYFSLLEGGR | 96 | P23743 | |
| SGCNLDSARFRYLIG | 161 | P07864 | |
| FVGRAGYLCAALVLK | 171 | Q6ZV70 | |
| LYEGFSGTVCFLIDL | 391 | Q6ZV70 | |
| LHGIYLRAFCTGLDS | 81 | Q9UGJ1 | |
| LTLQCGSDVGYDRFV | 241 | Q6PI73 | |
| ALLVAVSYCGGFINS | 141 | P0C7N8 | |
| KSELALSALGGCVFY | 676 | P52701 | |
| VLDVLLCLANYSRGG | 1056 | P52701 | |
| GGLVFACLYESGART | 431 | Q8WWR8 | |
| FSGLLLYLCDSFVGA | 1846 | Q9C091 | |
| IGCLATAAALTYGLY | 51 | Q9BW72 | |
| LTLYPCIGFRALGDS | 181 | P86480 | |
| LLITGLDRADAGCYT | 4956 | Q5VST9 | |
| LTLYPCIGFRALGDS | 181 | P86496 | |
| LTLYPCIGFRALGDS | 181 | P86481 | |
| LDVLRLNVGGCIYTA | 11 | Q6PI47 | |
| LNVGGCIYTARRESL | 16 | Q6PI47 | |
| VCERTLKYFLGIAGG | 1696 | P38398 | |
| GYLIRLFAGAESIAC | 276 | Q9ULW2 | |
| CYVGLSSVDALRGFV | 411 | O75084 | |
| RNLLLGTACAIYLGF | 36 | Q6UWH4 | |
| RILVLGCGNSALSYE | 61 | P0DPD8 | |
| LYESCQFFLSGLERG | 336 | Q14674 | |
| IGFLCTAAVLTNGLY | 51 | Q4VC39 | |
| LTLYCSALRFLNEGV | 396 | Q7L8L6 | |
| GTVCDFRLSYGRVLS | 351 | A1L0T0 | |
| YAVCALRNDILVSGG | 356 | Q6TFL4 | |
| VIRYSCSGTFRLIGE | 46 | P20023 | |
| RGLSAYAQACLELGI | 716 | Q9Y6R7 | |
| DLCSLLGGVDRYAVS | 546 | Q8TF46 | |
| AANGTCFTAGRLIYV | 316 | P82251 | |
| CFTAGRLIYVAGREG | 321 | P82251 | |
| GDLCYADLTLQLAGT | 201 | Q8TDQ1 | |
| FYSGILLLACISVDR | 121 | P25024 | |
| VIVGNYRCSLAGRDL | 506 | Q5U5Z8 | |
| ARRELDIGISATYCG | 176 | Q96NU7 | |
| LLLGAGVFACVTAYI | 201 | Q8N4S9 | |
| ACEAGRVTRYGIAVL | 291 | O75578 | |
| IARCSRGQYFGELAL | 341 | P31323 | |
| DVAVCSFRRVFLGLG | 651 | Q14831 | |
| CTRLYAADIVFLLDG | 31 | Q02388 | |
| GFCYLNDAVLGILRL | 151 | Q9BY41 | |
| ATLLGRYLCAGAVDF | 206 | P13807 | |
| ILVYCSLRFLAGAAT | 196 | Q6T423 | |
| GNLTCSEAGVYVLRF | 351 | Q9UDX4 | |
| GSLTCLQAGVYVLRF | 351 | Q9UDX3 | |
| GILTCLQAGSYVLRF | 351 | B5MCN3 | |
| VGYFADRFGRKLCLL | 166 | O15245 | |
| RGFLYEFCVGLSLGA | 101 | P0C263 | |
| LVSACDLLGVGAEYA | 161 | Q9Y6X3 | |
| IRYSGAACGLAFVFI | 506 | Q8NBW4 | |
| LSDGSYFGEICLLTR | 601 | Q9UL51 | |
| GRALDLLAGFYDACA | 1276 | Q96RY7 | |
| SSVLAGLCYAEFGAR | 76 | Q8WY07 | |
| EGILRGAATCFYAFV | 251 | Q8WY07 | |
| YSDGINVLGLIVFCL | 206 | P43005 | |
| YLAFVGLLASCLGLE | 6 | Q6N075 | |
| VVDCRAFGRYTLVGS | 1206 | Q9HC10 | |
| GCLSDYLRTQRGLFA | 441 | Q08881 | |
| RCVGIFLDYEAGVIS | 356 | Q96PL5 | |
| LITDYRVRLGCGSFA | 491 | Q2TAK8 | |
| LEEAFFLVYALGCLS | 301 | Q8NCE0 | |
| CLNRFVDEGSLYGLS | 416 | Q9Y5J1 | |
| CRVGVFLDYEAGIVS | 431 | Q9BYJ4 | |
| LGICLDYERGRVSFL | 691 | Q7Z4K8 | |
| LIDLDLYIGFNGCSL | 186 | Q6P1N9 | |
| IGFSLGARVIYFCLQ | 401 | Q5TGY1 | |
| VGYVGADLTALCREA | 401 | Q9BVQ7 | |
| FLVLRDGTGYLQCVL | 146 | O43776 | |
| CFLAAAHYGRGRVVL | 256 | A6NFQ2 | |
| FSYRGGRLDQLACTL | 216 | Q8N967 | |
| VGGLLSLSLDYCFVL | 756 | O60502 | |
| GFLGTFADYIRSVCR | 106 | Q96AM1 | |
| FLIYCSLRFLSGIAA | 196 | Q8IVM8 | |
| GFCLAGIILTLYALR | 291 | A1A5C7 | |
| RLRCGAVDLYFTLFG | 966 | Q6P1X5 | |
| ADLIDGYCRLVNGTS | 341 | Q05397 | |
| TGACLALVAVRLFSY | 216 | O15197 | |
| LVQLALADLYACGGT | 86 | Q8NGU9 | |
| LTLYPCIGFRALGDS | 181 | P86479 | |
| SGIRDYLGLFAVACF | 1091 | Q99707 | |
| YLGLFAVACFGVEEL | 1096 | Q99707 | |
| LTLYPCIGFRALGDS | 181 | P86478 | |
| RAILYVAQGTFGECS | 146 | Q5VSL9 | |
| SAALGLCEEVAIYGF | 281 | Q92185 | |
| LAYALARGFTAAGIL | 11 | Q96C36 | |
| AILTLLRTVGAEYCF | 401 | O60733 | |
| FLALYDFTARCGGEL | 56 | Q9H3Y6 | |
| RILVLGCGNSALSYE | 61 | P0DPD7 | |
| FNYCGLERALVEVLG | 166 | Q8TAY7 | |
| LDFVHLTALGYTLCG | 1586 | Q7RTU9 | |
| FGGADAARRYACLVT | 331 | Q96A09 | |
| FNGTRLGAVALYACD | 711 | Q8TER0 | |
| YVCAFLNSEGGSLLV | 246 | Q499Z3 | |
| ILRAADGFLFVVGCD | 151 | O00327 | |
| TVLGFLRAALGCQVY | 441 | Q9UKU0 | |
| RVALTGGVLYLFCGL | 116 | O00501 | |
| VGASYVALECAGFLA | 346 | Q16881 | |
| VLRASVGCGSEAARY | 1741 | Q63HN8 | |
| LYALFGGCVSISLEV | 151 | Q96B21 | |
| RGAGSLELYLDCIQV | 136 | P35443 | |
| RLLGKGGFARCYEAT | 66 | Q9H4B4 | |
| CGVLSLFGALSYAEL | 86 | Q9UPY5 | |
| GCLLQGTFYARERLG | 346 | Q9BZV1 | |
| DIDRGTFVCIYSGRL | 386 | Q96T68 | |
| EGCLRYFVLGTVAAL | 1286 | O94966 | |
| FCLRNLDGTLGYLLD | 16 | Q7Z7L7 | |
| GFEVLFACTGIALGY | 351 | Q9H1C4 | |
| IALGYGVCSVGLERL | 361 | Q9H1C4 | |
| GVCSVGLERLAYLLV | 366 | Q9H1C4 | |
| VYRAIAERLCALGFL | 516 | P17040 | |
| GSQRALRGLVYLFCS | 516 | P60852 | |
| GCYAEENGLRTLLAS | 631 | Q9NTN9 | |
| YLSVGAGCFVASILL | 226 | Q99442 | |
| GGCFLLTALYLERDE | 461 | Q6ZMD2 | |
| IIAYGGLRGAICFAL | 431 | Q9UBY0 | |
| IAFSGYCLVISALGL | 101 | Q96CE8 | |
| GALAALFCLQYLGVR | 71 | H0YL14 | |
| DASCLGRLGGIAVAY | 106 | P43007 | |
| LIAALASVLAGLCYG | 71 | P30825 | |
| ASVLAGLCYGEFGAR | 76 | P30825 | |
| CDIELVGAGYRFSLI | 801 | Q9BQI5 | |
| CGRELQRLSYLGAFF | 581 | O95155 | |
| LFSVFGALCYAELGT | 81 | Q9UM01 | |
| VCTLGAGLYARASFL | 181 | Q9BXP2 | |
| CRVGVAALNTLAGYI | 221 | Q9HAV4 | |
| ALRFGLILEAYCRGS | 661 | O00329 | |
| NACSYGVAVGVLAFL | 66 | O43759 | |
| AFGLVTLSLCVAYIG | 51 | Q96KF7 | |
| GVTACAAAGVLLYRI | 21 | Q5SNT2 | |
| DACRYGSAIGVLAFL | 66 | A8MWL6 | |
| DACRYGSAIGVLAFL | 66 | O43760 | |
| GSIFDCQGSLIAAYL | 31 | Q8N6L7 | |
| TILNLCAEYSRADGG | 616 | Q86UU1 | |
| VVFARGILCHYLEEG | 166 | O60656 | |
| VAVFLLSYAVPSCGR | 11 | P12272 | |
| ELAFAFGGLCERLVS | 1516 | P78527 | |
| IGGLFSVVGALCYAE | 86 | Q92536 | |
| ILSLSYDGTLRCGDF | 376 | Q9H967 | |
| ATYLALGVLSCLGFV | 191 | Q14656 | |
| ASYVALECAGFLTGI | 226 | Q9NNW7 | |
| RALRFGTECTLGYLD | 2236 | Q9Y4G6 | |
| VAIRNYGRLLCSTGE | 1021 | Q6PGP7 | |
| IFSCDDFYILGSGLV | 306 | Q8NHP8 | |
| REAAYGFFLLGGLCV | 96 | Q9NX00 | |
| LGLLGVYCYRAAIGS | 726 | Q5H8A4 | |
| SYNLLLVAARDCGLG | 321 | O75127 | |
| LFELRLYFCGLSDAV | 121 | O60602 | |
| GGLADCLLYLEFFSI | 561 | Q14669 | |
| LAGFARLCVGDQYEI | 216 | Q6ZS17 | |
| CRIGVFLDYEAGIVS | 441 | Q8IYM9 | |
| AFLLGYVAFRGSCQA | 96 | Q9UP52 | |
| HCFGSYILADLLLGE | 61 | Q9H6F2 | |
| NLTDGSILCGRRYFD | 211 | P45974 | |
| AAYTCVSRLGELGLV | 21 | Q13488 | |
| GRQLLLSCYSGVLEF | 81 | Q9HCK0 | |
| AYRVNLLCGLFGAVA | 91 | Q9NX78 | |
| YIERCLQDFLGFGVL | 191 | Q8WU03 | |
| DAVGVCLLGDRLYAV | 691 | Q9NR64 | |
| ETRLAELINCLAGGY | 46 | Q9H3M0 | |
| ELINCLAGGYDTIFS | 51 | Q9H3M0 |